Gelesis Holdings, Inc. (GLSHQ)
OTCMKTS: GLSHQ · Delayed Price · USD
0.0198
0.00 (0.00%)
Mar 20, 2024, 10:04 AM EDT - Market closed

Gelesis Holdings Market Cap

Gelesis Holdings has a market cap or net worth of $1.45 million as of April 16, 2024. Its market cap has decreased by -99.56% in one year.

Market Cap
1.45M
Enterprise Value
55.42M
1-Year Change
-99.56%
Ranking
n/a
Category
Stock Price
$0.02

Market Cap Chart

Since July 2, 2020, Gelesis Holdings's market cap has decreased from $255.50M to $1.45M, a decrease of -99.43%. That is a compound annual growth rate of -84.51%.

History

DateMarket Cap% Change
Apr 10, 202311.70M0.86%
Apr 6, 202311.60M-7.20%
Apr 5, 202312.50M-15.54%
Apr 4, 202314.80M23.33%
Apr 3, 202312.00M-
Mar 31, 202312.00M-4.00%
Mar 30, 202312.50M-10.07%
Mar 29, 202313.90M-
Mar 28, 202313.90M6.11%
Mar 27, 202313.10M5.65%
Mar 24, 202312.40M2.48%
Mar 23, 202312.10M13.08%
Mar 22, 202310.70M-6.96%
Mar 21, 202311.50M-24.84%
Mar 20, 202315.30M91.25%
Mar 17, 20238.00M-45.21%
Mar 16, 202314.60M0.69%
Mar 15, 202314.50M-7.64%
Mar 14, 202315.70M-5.99%
Mar 13, 202316.70M-4.57%
Mar 10, 202317.50M4.17%
Mar 9, 202316.80M-10.16%
Mar 8, 202318.70M-1.58%
Mar 7, 202319.00M4.40%
Mar 6, 202318.20M-2.15%
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 714.63B
Novo Nordisk 555.41B
UnitedHealth Group 404.91B
Johnson & Johnson 355.34B
Merck & Co. 318.45B
AbbVie 287.34B
Thermo Fisher 215.76B
AstraZeneca 213.67B
Market Cap Rankings